Exploring IB6 as a Therapeutic Target in Non–Small Cell Lung Cancer - Episode 2
Rationale for Evaluating IB6 as a Potential Therapeutic Target in NSCLC
Julia Rotow, MD, and Jyoti Malhotra, MD, MPH, discuss the rationale for evaluating IB6 as a target in non–small cell lung cancer.
Related Content:
